Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bonomo

Showing results (51-60 of 884) with videos related to

Pageof 89
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
beta -Lactamases: which ones are clinically important?Louis B. Rice, Robert A. Bonomo
Current Pharmaceutical Design|December 14, 1999
SHV-type beta-lactamasesL S Tzouvelekis, R A Bonomo
Advances in Experimental Medicine and Biology|August 1, 2019
Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' PolymyxinsDavid L Paterson, Robert A Bonomo
Clinical Microbiology Reviews|October 15, 2005
Extended-spectrum beta-lactamases: a clinical updateDavid L Paterson, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Macesic et alDavid van Duin, Robert A Bonomo
Expert Review of Anti-Infective Therapy|October 31, 2012
Reappraising the use of β-lactams to treat tuberculosisSebastian G Kurz, Robert A Bonomo
Infectious Disease Clinics of North America|October 4, 2020
Overview: The Ongoing Threat of Antimicrobial ResistanceRichard R Watkins, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2016
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor CombinationsDavid van Duin, Robert A Bonomo
Infectious Disease Clinics of North America|May 22, 2016
Antibiotic Resistance in the Twenty-First Century: Current Concepts and Future DirectionsRichard R Watkins, Robert A Bonomo
The Medical Journal of Australia|June 4, 2016
Medicinal cannabis in Australia: the missing linksJennifer H Martin, Yvonne A Bonomo
Pageof 89

Showing results (51-60 of 884) with videos related to

Sort By:
Pageof 89
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
beta -Lactamases: which ones are clinically important?Louis B. Rice, Robert A. Bonomo
Current Pharmaceutical Design|December 14, 1999
SHV-type beta-lactamasesL S Tzouvelekis, R A Bonomo
Advances in Experimental Medicine and Biology|August 1, 2019
Multidrug-Resistant Gram-Negative Pathogens: The Urgent Need for 'Old' PolymyxinsDavid L Paterson, Robert A Bonomo
Clinical Microbiology Reviews|October 15, 2005
Extended-spectrum beta-lactamases: a clinical updateDavid L Paterson, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Reply to Macesic et alDavid van Duin, Robert A Bonomo
Expert Review of Anti-Infective Therapy|October 31, 2012
Reappraising the use of β-lactams to treat tuberculosisSebastian G Kurz, Robert A Bonomo
Infectious Disease Clinics of North America|October 4, 2020
Overview: The Ongoing Threat of Antimicrobial ResistanceRichard R Watkins, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2016
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor CombinationsDavid van Duin, Robert A Bonomo
Infectious Disease Clinics of North America|May 22, 2016
Antibiotic Resistance in the Twenty-First Century: Current Concepts and Future DirectionsRichard R Watkins, Robert A Bonomo
The Medical Journal of Australia|June 4, 2016
Medicinal cannabis in Australia: the missing linksJennifer H Martin, Yvonne A Bonomo
Pageof 89